JPRN-UMIN000020829招募中未知
Desensitization therapy for preexisted anti-HLA antibody with anti-CD20 Antibody, plasma exchange, and immunoglobulin in kidney transplantation - desensitization therapy for preexisted anti-HLA antibody
Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University of Medicine0 个研究点目标入组 6 人开始时间: 2016年2月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) The patients with serious hypersensitivity or medical history of anaphylaxis for the products derived from mouse protein, Rituximab, immunoglobulin, and an integrent of the albumin to prepare plasma exchange. 2) The patients whom the medical attendant judged when the exacerbation of the sign exceeded benefit of Rituximab among them who have severe infectious diseases, a cardiac dysfunction, respiratory diseases, or a bone marrow dysfunction. 3) The patients with an medical history of the drug hypersensitivity and the allergic to albumin (preparation for plasma exchange), Rituximab or immunoglobulin whom the medical attendant judged when these adverse effects exceeded the benefits of these medications.
研究者
相似试验
已完成
4 期
Desensitization in Kidney TransplantationHLA SensitizationNCT00908583University of Cincinnati44
招募中
不适用
Desensitization with rituximab for preformed anti-donor antibody and antibody-mediated rejection in kidney transplantation.end stage renal diseaseJPRN-UMIN000032113Hyogo College of Medicine90
已完成
不适用
First-Line Immunosuppressive Therapies for Acquired Hemophilia A: A 25-year Cohort Experience and Network Meta-Analysis Short title: First-Line Immunosuppressive Therapies in AHAAcquired hemophiliaAcquired hemophilia AComplete remissionImmunosuppressive treatmentRelapseTCTR20240405005/A76
招募中
2 期
Conversion of unresponsiveness to immunotherapy by Fecal Microbiota Transplantation in patients with metastatic melanoma and non-melanoma skin cancer: a randomized phase Ib/IIa trial10040900melanomaskin cancerNL-OMON52200Antoni van Leeuwenhoek Ziekenhuis28
进行中（未招募）
不适用
Inmunoterapia con extracto alergénico despigmentado y polimerizado con glutaraldehído de Phleum pratense, en pacientes afectos de rinoconjuntivitis y/o asma alérgicosRinoconjuntivitis y asma por hipersensibilidad frente al polen de Phleum pratense.EUCTR2006-001437-18-ESaboratorios LETI, S.L. Unipersonal